A world leader in the field of in vitro diagnostics for over 50 years, bioMérieux is present in more than 150 countries through 42 subsidiaries and a large network of distributors. In 2016, revenues reached €2,103 million, with more than 90% of international sales.
2016 was an outstanding year for bioMérieux. We achieved excellent results in a balanced performance across all areas of the business. Today bioMérieux’s footprint places us among the industry elite. With nearly 10,000 employees and revenues up 9.6% to reach more than €2 billion, the Company is the world leader in microbiology, in both infectious disease diagnostics and industrial quality control. These remarkable results once again demonstrate the relevance of a long-term strategy that we are able to successfully implement in over 150 countries through our extremely solid network.
Sustained by our sound innovation strategy, the relevance of our acquisitions, the solidity of our bioindustrial fundamentals and the quality of our international network, we are poised to be a major player in the medicine of tomorrow.
bioMérieux has a clear vision for the future, and today we have the means to support our ambitions. Under the leadership of Alexander Mérieux, the Company will be ready to evolve and to serve global public health even more closely.
Download the Full Report: